| title | author | package | output | output_dir | vignette | date | link-citations |
|---|---|---|---|---|---|---|---|
MultiNicheNet analysis: SCC paired analysis - wrapper function |
Robin Browaeys |
multinichenetr 2.0.0 |
BiocStyle::html_document |
/Users/robinb/Work/multinichenetr/vignettes |
%\VignetteIndexEntry{MultiNicheNet analysis: SCC paired analysis - wrapper function} %\VignetteEngine{knitr::rmarkdown} %\VignetteEncoding{UTF-8}
|
16 April 2024 |
true |
In this vignette, you can learn how to perform a MultiNicheNet analysis to compare cell-cell communication between two conditions of interest (one-vs-one comparison) in a paired design setting. A MultiNicheNet analysis can be performed if you have multi-sample, multi-condition/group single-cell data. We strongly recommend having at least 4 samples in each of the groups/conditions you want to compare. With less samples, the benefits of performing a pseudobulk-based DE analysis are less clear. For those datasets, you can check and run our alternative workflow that makes use of cell-level sample-agnostic differential expression tools.
As input you need a SingleCellExperiment object containing at least the raw count matrix and metadata providing the following information for each cell: the group, sample and cell type.
As example expression data of interacting cells, we will here use scRNAseq data of patients with squamous cell carcinoma from this paper of Ji et al.: Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma. We have data of normal and tumor tissue for each patient, and thus a paired design.
We will use MultiNicheNet to explore tumor microenvironment interactions that are different between tumor and normal tissue. In this vignette, we will prepare the data and analysis parameters, and then perform the MultiNicheNet analysis. In contrast to a classic pairwise analysis between conditions/groups, we will here demonstrate how you can include in the DE model that tumor and healthy tissue come from the same patient.
We will first prepare the MultiNicheNet core analysis, then run the several steps in the MultiNicheNet core analysis, and finally interpret the output.
library(SingleCellExperiment)
library(dplyr)
library(ggplot2)
library(nichenetr)
library(multinichenetr)MultiNicheNet builds upon the NicheNet framework and uses the same prior knowledge networks (ligand-receptor network and ligand-target matrix, currently v2 version).
The Nichenet v2 networks and matrices for both mouse and human can be downloaded from Zenodo 
We will read these object in for human because our expression data is of human patients.
Gene names are here made syntactically valid via make.names() to avoid the loss of genes (eg H2-M3) in downstream visualizations.
organism = "human"options(timeout = 120)
if(organism == "human"){
lr_network_all =
readRDS(url(
"https://zenodo.org/record/10229222/files/lr_network_human_allInfo_30112033.rds"
)) %>%
mutate(
ligand = convert_alias_to_symbols(ligand, organism = organism),
receptor = convert_alias_to_symbols(receptor, organism = organism))
lr_network_all = lr_network_all %>%
mutate(ligand = make.names(ligand), receptor = make.names(receptor))
lr_network = lr_network_all %>%
distinct(ligand, receptor)
ligand_target_matrix = readRDS(url(
"https://zenodo.org/record/7074291/files/ligand_target_matrix_nsga2r_final.rds"
))
colnames(ligand_target_matrix) = colnames(ligand_target_matrix) %>%
convert_alias_to_symbols(organism = organism) %>% make.names()
rownames(ligand_target_matrix) = rownames(ligand_target_matrix) %>%
convert_alias_to_symbols(organism = organism) %>% make.names()
lr_network = lr_network %>% filter(ligand %in% colnames(ligand_target_matrix))
ligand_target_matrix = ligand_target_matrix[, lr_network$ligand %>% unique()]
} else if(organism == "mouse"){
lr_network_all = readRDS(url(
"https://zenodo.org/record/10229222/files/lr_network_mouse_allInfo_30112033.rds"
)) %>%
mutate(
ligand = convert_alias_to_symbols(ligand, organism = organism),
receptor = convert_alias_to_symbols(receptor, organism = organism))
lr_network_all = lr_network_all %>%
mutate(ligand = make.names(ligand), receptor = make.names(receptor))
lr_network = lr_network_all %>%
distinct(ligand, receptor)
ligand_target_matrix = readRDS(url(
"https://zenodo.org/record/7074291/files/ligand_target_matrix_nsga2r_final_mouse.rds"
))
colnames(ligand_target_matrix) = colnames(ligand_target_matrix) %>%
convert_alias_to_symbols(organism = organism) %>% make.names()
rownames(ligand_target_matrix) = rownames(ligand_target_matrix) %>%
convert_alias_to_symbols(organism = organism) %>% make.names()
lr_network = lr_network %>% filter(ligand %in% colnames(ligand_target_matrix))
ligand_target_matrix = ligand_target_matrix[, lr_network$ligand %>% unique()]
}In this vignette, we will load in a subset of the scRNAseq data of the Ji el al Squamous Cell Carcinoma data. For the sake of demonstration, this subset only contains 4 cell types.
If you start from a Seurat object, you can convert it easily to a SingleCellExperiment object via sce = Seurat::as.SingleCellExperiment(seurat_obj, assay = "RNA").
Because the NicheNet 2.0. networks are in the most recent version of the official gene symbols, we will make sure that the gene symbols used in the expression data are also updated (= converted from their "aliases" to official gene symbols). Afterwards, we will make them again syntactically valid.
sce = readRDS(url(
"https://zenodo.org/record/8010790/files/sce_subset_scc.rds"
))
sce = alias_to_symbol_SCE(sce, "human") %>% makenames_SCE()In this step, we will formalize our research question into MultiNicheNet input arguments.
In this case study, we want to study differences in cell-cell communication patterns between cells in tumor tissue and healthy tissue. The meta data columns that indicate this tissue status is tum.norm (values: Tumor and Normal).
Cell type annotations are indicated in the celltype_alt column, and the sample is indicated by the sample_id column.
If your cells are annotated in multiple hierarchical levels, we recommend using a relatively high level in the hierarchy. This for 2 reasons: 1) MultiNicheNet focuses on differential expression and not differential abundance, and 2) there should be sufficient cells per sample-celltype combination (see later).
sample_id = "sample_id"
group_id = "tum.norm"
celltype_id = "celltype_alt"Important: It is required that each sample-id is uniquely assigned to only one condition/group of interest. See the vignettes about paired and multifactorial analysis to see how to define your analysis input when you have multiple samples (and conditions) per patient.
If you would have batch effects or covariates you can correct for, you can define this here as well. For this dataset, we can set the patient ID (given by the patient column) as covariate. Important: for a MultiNicheNet analysis there is a difference between a covariate and batch in the following sense: covariates will just be included in the DE GLM model, whereas batches will be included in the DE GLM model AND normalized pseudobulk expression values will be corrected for the batch effects. In this dataset, we want to take into account the patient effect, but not correct the expression values for the patient effect. Therefore we add patient as covariate and not as batch.
covariates = "patient"
batches = NAImportant: for categorical covariates and batches, there should be at least one sample for every group-batch combination. If one of your groups/conditions lacks a certain level of your batch, you won't be able to correct for the batch effect because the model is then not able to distinguish batch from group/condition effects.
Important: The column names of group, sample, cell type, batches and covariates should be syntactically valid (make.names)
Important: All group, sample, cell type, batch and covariate names should be syntactically valid as well (make.names) (eg through SummarizedExperiment::colData(sce)$ShortID = SummarizedExperiment::colData(sce)$ShortID %>% make.names())
For this analysis, we want to compare Tumor tissue and normal tissue. To do this comparison, we need to set the following contrasts:
contrasts_oi = c("'Tumor-Normal','Normal-Tumor'")Very Important Note the format to indicate the contrasts! This formatting should be adhered to very strictly, and white spaces are not allowed! Check ?get_DE_info for explanation about how to define this well. The most important points are that:
*each contrast is surrounded by single quotation marks
*contrasts are separated by a comma without any white space
*all contrasts together are surrounded by double quotation marks.
If you compare against two groups, you should divide by 2 (as demonstrated in other vignettes), if you compare against three groups, you should divide by 3 and so on.
For downstream visualizations and linking contrasts to their main condition, we also need to run the following: This is necessary because we will also calculate cell-type+condition specificity of ligands and receptors.
contrast_tbl = tibble(contrast =
c("Tumor-Normal", "Normal-Tumor"),
group = c("Tumor", "Normal"))Other vignettes will demonstrate how to formalize different types of research questions.
If you want to focus the analysis on specific cell types (e.g. because you know which cell types reside in the same microenvironments based on spatial data), you can define this here. If you have sufficient computational resources and no specific idea of cell-type colocalzations, we recommend to consider all cell types as potential senders and receivers. Later on during analysis of the output it is still possible to zoom in on the cell types that interest you most, but your analysis is not biased to them.
Here we will consider all cell types in the data:
senders_oi = SummarizedExperiment::colData(sce)[,celltype_id] %>% unique()
receivers_oi = SummarizedExperiment::colData(sce)[,celltype_id] %>% unique()
sce = sce[, SummarizedExperiment::colData(sce)[,celltype_id] %in%
c(senders_oi, receivers_oi)
]In case you would have samples in your data that do not belong to one of the groups/conditions of interest, we recommend removing them and only keeping conditions of interest:
conditions_keep = c("Normal", "Tumor")
sce = sce[, SummarizedExperiment::colData(sce)[,group_id] %in%
conditions_keep
]Now we will run the core of a MultiNicheNet analysis. This analysis consists of the following steps:
-
- Cell-type filtering: determine which cell types are sufficiently present
-
- Gene filtering: determine which genes are sufficiently expressed in each present cell type
-
- Pseudobulk expression calculation: determine and normalize per-sample pseudobulk expression levels for each expressed gene in each present cell type
-
- Differential expression (DE) analysis: determine which genes are differentially expressed
-
- Ligand activity prediction: use the DE analysis output to predict the activity of ligands in receiver cell types and infer their potential target genes
-
- Prioritization: rank cell-cell communication patterns through multi-criteria prioritization
Following these steps, one can optionally
-
- Calculate the across-samples expression correlation between ligand-receptor pairs and target genes
-
- Prioritize communication patterns involving condition-specific cell types through an alternative prioritization scheme
After these steps, the output can be further explored as we will demonstrate in the "Downstream analysis of the MultiNicheNet output" section.
In this vignette, we will demonstrate these steps one-by-one, which offers the most flexibility to the user to assess intermediary results. Other vignettes will demonstrate the use of the multi_nichenet_analysis wrapper function.
In this step we will calculate and visualize cell type abundances. This will give an indication about which cell types will be retained in the analysis, and which cell types will be filtered out.
Since MultiNicheNet will infer group differences at the sample level for each cell type (currently via Muscat - pseudobulking + EdgeR), we need to have sufficient cells per sample of a cell type, and this for all groups. In the following analysis we will set this minimum number of cells per cell type per sample at 10. Samples that have less than min_cells cells will be excluded from the analysis for that specific cell type.
min_cells = 10We recommend using min_cells = 10, except for datasets with several lowly abundant cell types of interest. For those datasets, we recommend using min_cells = 5.
abundance_info = get_abundance_info(
sce = sce,
sample_id = sample_id, group_id = group_id, celltype_id = celltype_id,
min_cells = min_cells,
senders_oi = senders_oi, receivers_oi = receivers_oi,
batches = batches
)First, we will check the cell type abundance diagnostic plots.
The first plot visualizes the number of cells per celltype-sample combination, and indicates which combinations are removed during the DE analysis because there are less than min_cells in the celltype-sample combination.
abundance_info$abund_plot_sample
The red dotted line indicates the required minimum of cells as defined above in min_cells. We can see here that some sample-celltype combinations are left out. For the DE analysis in the next step, only cell types will be considered if there are at least two samples per group with a sufficient number of cells. But as we can see here: all cell types will be considered for the analysis and there are no condition-specific cell types.
Important: Based on the cell type abundance diagnostics, we recommend users to change their analysis settings if required (eg changing cell type annotation level, batches, ...), before proceeding with the rest of the analysis. If too many celltype-sample combinations don't pass this threshold, we recommend to define your cell types in a more general way (use one level higher of the cell type ontology hierarchy) (eg TH17 CD4T cells --> CD4T cells) or use min_cells = 5 if this would not be possible.
You can always explore this plot for a more lenient or stringent setting of min_cells in case of doubt. In this case study, it may be useful to be more lenient. Why? Because we added the Patient ID as covariate, we need to have sufficient cells of one patient for BOTH tumor and normal tissue to include that patient in the DE analysis. Since we seem to have many "borderline" cases here and could up with a low nr of included patients, we will drop our stringency level.
min_cells = 5
abundance_info = get_abundance_info(
sce = sce,
sample_id = sample_id, group_id = group_id, celltype_id = celltype_id,
min_cells = min_cells,
senders_oi = senders_oi, receivers_oi = receivers_oi,
batches = batches
)
abundance_info$abund_plot_sample
Running the following block of code can help you determine which cell types are condition-specific and which cell types are absent.
sample_group_celltype_df = abundance_info$abundance_data %>%
filter(n > min_cells) %>%
ungroup() %>%
distinct(sample_id, group_id) %>%
cross_join(
abundance_info$abundance_data %>%
ungroup() %>%
distinct(celltype_id)
) %>%
arrange(sample_id)
abundance_df = sample_group_celltype_df %>% left_join(
abundance_info$abundance_data %>% ungroup()
)
abundance_df$n[is.na(abundance_df$n)] = 0
abundance_df$keep[is.na(abundance_df$keep)] = FALSE
abundance_df_summarized = abundance_df %>%
mutate(keep = as.logical(keep)) %>%
group_by(group_id, celltype_id) %>%
summarise(samples_present = sum((keep)))
celltypes_absent_one_condition = abundance_df_summarized %>%
filter(samples_present == 0) %>% pull(celltype_id) %>% unique()
# find truly condition-specific cell types by searching for cell types
# truely absent in at least one condition
celltypes_present_one_condition = abundance_df_summarized %>%
filter(samples_present >= 2) %>% pull(celltype_id) %>% unique()
# require presence in at least 2 samples of one group so
# it is really present in at least one condition
condition_specific_celltypes = intersect(
celltypes_absent_one_condition,
celltypes_present_one_condition)
total_nr_conditions = SummarizedExperiment::colData(sce)[,group_id] %>%
unique() %>% length()
absent_celltypes = abundance_df_summarized %>%
filter(samples_present < 2) %>%
group_by(celltype_id) %>%
count() %>%
filter(n == total_nr_conditions) %>%
pull(celltype_id)
print("condition-specific celltypes:")
## [1] "condition-specific celltypes:"
print(condition_specific_celltypes)
## character(0)
print("absent celltypes:")
## [1] "absent celltypes:"
print(absent_celltypes)
## character(0)Absent cell types will be filtered out, condition-specific cell types can be filtered out if you as a user do not want to run the alternative workflow for condition-specific cell types in the optional step 8 of the core MultiNicheNet analysis.
For this dataset, there are no condition-specific or absent cell types, so this does not really matter.
analyse_condition_specific_celltypes = FALSEif(analyse_condition_specific_celltypes == TRUE){
senders_oi = senders_oi %>% setdiff(absent_celltypes)
receivers_oi = receivers_oi %>% setdiff(absent_celltypes)
} else {
senders_oi = senders_oi %>%
setdiff(union(absent_celltypes, condition_specific_celltypes))
receivers_oi = receivers_oi %>%
setdiff(union(absent_celltypes, condition_specific_celltypes))
}
sce = sce[, SummarizedExperiment::colData(sce)[,celltype_id] %in%
c(senders_oi, receivers_oi)
]Before running the DE analysis, we will determine which genes are not sufficiently expressed and should be filtered out.
We will perform gene filtering based on a similar procedure as used in edgeR::filterByExpr. However, we adapted this procedure to be more interpretable for single-cell datasets.
For each cell type, we will consider genes expressed if they are expressed in at least a min_sample_prop fraction of samples in the condition with the lowest number of samples. By default, we set min_sample_prop = 0.50, which means that genes should be expressed in at least 2 samples if the group with lowest nr. of samples has 4 samples like this dataset.
min_sample_prop = 0.50But how do we define which genes are expressed in a sample? For this we will consider genes as expressed if they have non-zero expression values in a fraction_cutoff fraction of cells of that cell type in that sample. By default, we set fraction_cutoff = 0.05, which means that genes should show non-zero expression values in at least 5% of cells in a sample.
fraction_cutoff = 0.05We recommend using these default values unless there is specific interest in prioritizing (very) weakly expressed interactions. In that case, you could lower the value of fraction_cutoff. We explicitly recommend against using fraction_cutoff > 0.10.
Now we will calculate the information required for gene filtering with the following command:
frq_list = get_frac_exprs(
sce = sce,
sample_id = sample_id, celltype_id = celltype_id, group_id = group_id,
batches = batches,
min_cells = min_cells,
fraction_cutoff = fraction_cutoff, min_sample_prop = min_sample_prop)
## [1] "Samples are considered if they have more than 5 cells of the cell type of interest"
## [1] "Genes with non-zero counts in at least 5% of cells of a cell type of interest in a particular sample will be considered as expressed in that sample."
## [1] "Genes expressed in at least 3 samples will considered as expressed in the cell type: CD8T"
## [1] "Genes expressed in at least 3 samples will considered as expressed in the cell type: CLEC9A"
## [1] "Genes expressed in at least 4 samples will considered as expressed in the cell type: Fibroblast"
## [1] "Genes expressed in at least 5 samples will considered as expressed in the cell type: KC_other"
## [1] "7915 genes are considered as expressed in the cell type: CD8T"
## [1] "8901 genes are considered as expressed in the cell type: CLEC9A"
## [1] "10494 genes are considered as expressed in the cell type: Fibroblast"
## [1] "10982 genes are considered as expressed in the cell type: KC_other"Now only keep genes that are expressed by at least one cell type:
genes_oi = frq_list$expressed_df %>%
filter(expressed == TRUE) %>% pull(gene) %>% unique()
sce = sce[genes_oi, ]Pseudobulk expression calculation: determine and normalize per-sample pseudobulk expression levels for each expressed gene in each present cell type
After filtering out absent cell types and genes, we will continue the analysis by calculating the different prioritization criteria that we will use to prioritize cell-cell communication patterns.
First, we will determine and normalize per-sample pseudobulk expression levels for each expressed gene in each present cell type. The function process_abundance_expression_info will link this expression information for ligands of the sender cell types to the corresponding receptors of the receiver cell types. This will later on allow us to define the cell-type specicificy criteria for ligands and receptors.
abundance_expression_info = process_abundance_expression_info(
sce = sce,
sample_id = sample_id, group_id = group_id, celltype_id = celltype_id,
min_cells = min_cells,
senders_oi = senders_oi, receivers_oi = receivers_oi,
lr_network = lr_network,
batches = batches,
frq_list = frq_list,
abundance_info = abundance_info)Normalized pseudobulk expression values per gene/celltype/sample can be inspected by:
abundance_expression_info$celltype_info$pb_df %>% head()
## # A tibble: 6 × 4
## gene sample pb_sample celltype
## <chr> <chr> <dbl> <fct>
## 1 A1BG P10Normal 2.18 KC_other
## 2 A1BG.AS1 P10Normal 1.64 KC_other
## 3 A2M P10Normal 3.24 KC_other
## 4 A2ML1 P10Normal 3.92 KC_other
## 5 A4GALT P10Normal 0 KC_other
## 6 AAAS P10Normal 4.60 KC_otherAn average of these sample-level expression values per condition/group can be inspected by:
abundance_expression_info$celltype_info$pb_df_group %>% head()
## # A tibble: 6 × 4
## # Groups: group, celltype [1]
## group celltype gene pb_group
## <chr> <chr> <chr> <dbl>
## 1 Normal CD8T A1BG 6.06
## 2 Normal CD8T A1BG.AS1 1.22
## 3 Normal CD8T A2M 0
## 4 Normal CD8T A2ML1 0
## 5 Normal CD8T A4GALT 0
## 6 Normal CD8T AAAS 3.20Inspecting these values for ligand-receptor interactions can be done by:
abundance_expression_info$sender_receiver_info$pb_df %>% head()
## # A tibble: 6 × 8
## sample sender receiver ligand receptor pb_ligand pb_receptor ligand_receptor_pb_prod
## <chr> <chr> <chr> <chr> <chr> <dbl> <dbl> <dbl>
## 1 P6Normal CLEC9A Fibroblast HLA.DRA CD63 14.9 12.3 184.
## 2 P10Tumor CLEC9A Fibroblast HLA.DRA CD63 15.2 11.8 180.
## 3 P4Tumor CLEC9A Fibroblast HLA.DRA CD63 15.3 11.6 178.
## 4 P4Tumor CLEC9A CLEC9A HLA.DMA CD74 10.8 16.0 172.
## 5 P10Normal CLEC9A Fibroblast HLA.DRA CD63 14.6 11.7 171.
## 6 P2Tumor CLEC9A Fibroblast HLA.DRA CD63 14.5 11.7 169.
abundance_expression_info$sender_receiver_info$pb_df_group %>% head()
## # A tibble: 6 × 8
## # Groups: group, sender [2]
## group sender receiver ligand receptor pb_ligand_group pb_receptor_group ligand_receptor_pb_prod_group
## <chr> <chr> <chr> <chr> <chr> <dbl> <dbl> <dbl>
## 1 Normal CLEC9A Fibroblast HLA.DRA CD63 14.5 11.5 167.
## 2 Tumor CLEC9A Fibroblast HLA.DRA CD63 14.4 11.5 167.
## 3 Normal CLEC9A CLEC9A HLA.DMA CD74 10.0 15.3 154.
## 4 Tumor CLEC9A CLEC9A HLA.DMA CD74 9.83 15.1 149.
## 5 Normal CLEC9A KC_other HLA.DRA CD9 14.5 9.75 141.
## 6 Normal CLEC9A Fibroblast HLA.DRA CD9 14.5 9.63 140.In this step, we will perform genome-wide differential expression analysis of receiver and sender cell types to define DE genes between the conditions of interest (as formalized by the contrasts_oi). Based on this analysis, we later can define the levels of differential expression of ligands in senders and receptors in receivers, and define the set of affected target genes in the receiver cell types (which will be used for the ligand activity analysis).
We will apply pseudobulking followed by EdgeR to perform multi-condition multi-sample differential expression (DE) analysis (also called 'differential state' analysis by the developers of Muscat).
DE_info = get_DE_info(
sce = sce,
sample_id = sample_id, group_id = group_id, celltype_id = celltype_id,
batches = batches, covariates = covariates,
contrasts_oi = contrasts_oi,
min_cells = min_cells,
expressed_df = frq_list$expressed_df)
## [1] "DE analysis is done:"
## [1] "included cell types are:"
## [1] "KC_other" "Fibroblast" "CLEC9A" "CD8T"Check DE output information in table with logFC and p-values for each gene-celltype-contrast:
DE_info$celltype_de$de_output_tidy %>% head()
## # A tibble: 6 × 9
## gene cluster_id logFC logCPM F p_val p_adj.loc p_adj contrast
## <chr> <chr> <dbl> <dbl> <dbl> <dbl> <dbl> <dbl> <chr>
## 1 A1BG KC_other 0.379 2.88 0.46 0.505 0.749 0.749 Tumor-Normal
## 2 A2ML1 KC_other 0.41 4.79 0.47 0.501 0.746 0.746 Tumor-Normal
## 3 AAAS KC_other 0.362 4.54 1.93 0.179 0.433 0.433 Tumor-Normal
## 4 AACS KC_other -0.651 4.78 5.01 0.0365 0.177 0.177 Tumor-Normal
## 5 AADACL2 KC_other -2.54 2.84 8.45 0.00968 0.0835 0.0835 Tumor-Normal
## 6 AAGAB KC_other 0.816 4.69 9.14 0.00664 0.0674 0.0674 Tumor-NormalEvaluate the distributions of p-values:
DE_info$hist_pvals
These distributions look fine (uniform distribution, except peak at p-value <= 0.05), so we will continue using these regular p-values. In case these p-value distributions look irregular, you can estimate empirical p-values as we will demonstrate in another vignette.
empirical_pval = FALSEif(empirical_pval == TRUE){
DE_info_emp = get_empirical_pvals(DE_info$celltype_de$de_output_tidy)
celltype_de = DE_info_emp$de_output_tidy_emp %>% select(-p_val, -p_adj) %>%
rename(p_val = p_emp, p_adj = p_adj_emp)
} else {
celltype_de = DE_info$celltype_de$de_output_tidy
} To end this step, we will combine the DE information of senders and receivers by linking their ligands and receptors together based on the prior knowledge ligand-receptor network.
sender_receiver_de = combine_sender_receiver_de(
sender_de = celltype_de,
receiver_de = celltype_de,
senders_oi = senders_oi,
receivers_oi = receivers_oi,
lr_network = lr_network
)sender_receiver_de %>% head(20)
## # A tibble: 20 × 12
## contrast sender receiver ligand receptor lfc_ligand lfc_receptor ligand_receptor_lfc_avg p_val_ligand p_adj_ligand p_val_receptor p_adj_receptor
## <chr> <chr> <chr> <chr> <chr> <dbl> <dbl> <dbl> <dbl> <dbl> <dbl> <dbl>
## 1 Tumor-Normal Fibroblast Fibroblast MMP1 F2R 11.6 1.81 6.70 1.02e-84 1.07e-80 3.96e- 5 1.27e- 3
## 2 Tumor-Normal KC_other Fibroblast TPSAB1 F2RL1 11.2 1.23 6.22 2.36e-14 2.59e-10 2.04e- 1 7.1 e- 1
## 3 Tumor-Normal Fibroblast CD8T CCL5 CCR1 7.54 4.64 6.09 2.82e-19 1.18e-16 3 e- 2 8.66e- 1
## 4 Tumor-Normal Fibroblast Fibroblast TIMP1 MMP1 0.434 11.6 6.02 1.49e- 1 6.3 e- 1 1.02e-84 1.07e-80
## 5 Tumor-Normal KC_other Fibroblast TIMP1 MMP1 0.306 11.6 5.95 2.01e- 1 4.61e- 1 1.02e-84 1.07e-80
## 6 Tumor-Normal Fibroblast CD8T MMP1 F2R 11.6 0.0622 5.83 1.02e-84 1.07e-80 9.34e- 1 9.99e- 1
## 7 Tumor-Normal Fibroblast KC_other MMP1 ITGA2 11.6 -0.0228 5.79 1.02e-84 1.07e-80 9.35e- 1 9.78e- 1
## 8 Tumor-Normal Fibroblast KC_other MMP1 CD44 11.6 -0.333 5.63 1.02e-84 1.07e-80 2.02e- 1 4.62e- 1
## 9 Tumor-Normal CLEC9A Fibroblast TIMP1 MMP1 -0.366 11.6 5.62 2.49e- 1 7.46e- 1 1.02e-84 1.07e-80
## 10 Tumor-Normal KC_other KC_other TPSAB1 F2RL1 11.2 -0.113 5.54 2.36e-14 2.59e-10 7.54e- 1 8.98e- 1
## 11 Tumor-Normal Fibroblast CD8T MMP1 CD44 11.6 -0.534 5.53 1.02e-84 1.07e-80 1.87e- 1 9.99e- 1
## 12 Tumor-Normal Fibroblast KC_other MMP1 F2R 11.6 -0.812 5.39 1.02e-84 1.07e-80 8.63e- 2 2.9 e- 1
## 13 Tumor-Normal Fibroblast Fibroblast MMP1 CD44 11.6 -0.859 5.37 1.02e-84 1.07e-80 8.38e- 3 1.07e- 1
## 14 Tumor-Normal Fibroblast CLEC9A MMP1 CD44 11.6 -1.13 5.24 1.02e-84 1.07e-80 2.16e- 4 1.03e- 2
## 15 Tumor-Normal CD8T Fibroblast TIMP1 MMP1 -1.23 11.6 5.18 1.44e- 2 6.78e- 1 1.02e-84 1.07e-80
## 16 Tumor-Normal CLEC9A CLEC9A CCL19 CCR7 6.21 3.88 5.04 5.79e-37 5.15e-33 9.38e-21 2.09e-17
## 17 Tumor-Normal Fibroblast KC_other CCN4 ITGA5 4.57 5.16 4.86 7.78e-10 6.75e- 8 1.33e- 8 1.83e- 5
## 18 Tumor-Normal CLEC9A Fibroblast CXCL13 ACKR4 8.58 1.12 4.85 4.87e-16 6.20e-13 1.07e- 2 1.27e- 1
## 19 Tumor-Normal Fibroblast CD8T INHBA ACVR1 4.85 4.65 4.75 1.12e-23 7.33e-21 2.92e- 2 8.51e- 1
## 20 Tumor-Normal CLEC9A CD8T CXCL13 CXCR3 8.58 0.897 4.74 4.87e-16 6.20e-13 1.27e- 1 9.99e- 1Ligand activity prediction: use the DE analysis output to predict the activity of ligands in receiver cell types and infer their potential target genes
In this step, we will predict NicheNet ligand activities and NicheNet ligand-target links based on these differential expression results. We do this to prioritize interactions based on their predicted effect on a receiver cell type. We will assume that the most important group-specific interactions are those that lead to group-specific gene expression changes in a receiver cell type.
Similarly to base NicheNet (https://github.com/saeyslab/nichenetr), we use the DE output to create a "geneset of interest": here we assume that DE genes within a cell type may be DE because of differential cell-cell communication processes. In the ligand activity prediction, we will assess the enrichment of target genes of ligands within this geneset of interest. In case high-probabiliy target genes of a ligand are enriched in this set compared to the background of expressed genes, we predict that this ligand may have a high activity.
Because the ligand activity analysis is an enrichment procedure, it is important that this geneset of interest should contain a sufficient but not too large number of genes. The ratio geneset_oi/background should ideally be between 1/200 and 1/10 (or close to these ratios).
To determine the genesets of interest based on DE output, we need to define some logFC and/or p-value thresholds per cell type/contrast combination. In general, we recommend inspecting the nr. of DE genes for all cell types based on the default thresholds and adapting accordingly. By default, we will apply the p-value cutoff on the normal p-values, and not on the p-values corrected for multiple testing. This choice was made because most multi-sample single-cell transcriptomics datasets have just a few samples per group and we might have a lack of statistical power due to pseudobulking. But, if the smallest group >= 20 samples, we typically recommend using p_val_adj = TRUE. When the biological difference between the conditions is very large, we typically recommend increasing the logFC_threshold and/or using p_val_adj = TRUE.
Assess geneset_oi-vs-background ratios for different DE output tresholds prior to the NicheNet ligand activity analysis
We will first inspect the geneset_oi-vs-background ratios for the default tresholds:
logFC_threshold = 0.50
p_val_threshold = 0.05p_val_adj = FALSE geneset_assessment = contrast_tbl$contrast %>%
lapply(
process_geneset_data,
celltype_de, logFC_threshold, p_val_adj, p_val_threshold
) %>%
bind_rows()
geneset_assessment
## # A tibble: 8 × 12
## cluster_id n_background n_geneset_up n_geneset_down prop_geneset_up prop_geneset_down in_range_up in_range_down contrast logFC_threshold p_val_threshold adjusted
## <chr> <int> <int> <int> <dbl> <dbl> <lgl> <lgl> <chr> <dbl> <dbl> <lgl>
## 1 CD8T 7915 310 73 0.0392 0.00922 TRUE TRUE Tumor-Normal 0.5 0.05 FALSE
## 2 CLEC9A 8901 700 427 0.0786 0.0480 TRUE TRUE Tumor-Normal 0.5 0.05 FALSE
## 3 Fibroblast 10494 712 746 0.0678 0.0711 TRUE TRUE Tumor-Normal 0.5 0.05 FALSE
## 4 KC_other 10982 1373 1102 0.125 0.100 FALSE FALSE Tumor-Normal 0.5 0.05 FALSE
## 5 CD8T 7915 73 310 0.00922 0.0392 TRUE TRUE Normal-Tumor 0.5 0.05 FALSE
## 6 CLEC9A 8901 427 700 0.0480 0.0786 TRUE TRUE Normal-Tumor 0.5 0.05 FALSE
## 7 Fibroblast 10494 746 712 0.0711 0.0678 TRUE TRUE Normal-Tumor 0.5 0.05 FALSE
## 8 KC_other 10982 1102 1373 0.100 0.125 FALSE FALSE Normal-Tumor 0.5 0.05 FALSEWe can see here that for all cell type / contrast combinations, all geneset/background ratio's are within the recommended range (in_range_up and in_range_down columns). When these geneset/background ratio's would not be within the recommended ranges, we should interpret ligand activity results for these cell types with more caution, or use different thresholds (for these or all cell types).
Because we are only out of range for the KC_other cell type, we will explore these ratio's in case we would increase the stringency of the logFC cutoff a little bit.
logFC_threshold = 0.75geneset_assessment = contrast_tbl$contrast %>%
lapply(
process_geneset_data,
celltype_de, logFC_threshold, p_val_adj = p_val_adj, p_val_threshold
) %>%
bind_rows()
geneset_assessment
## # A tibble: 8 × 12
## cluster_id n_background n_geneset_up n_geneset_down prop_geneset_up prop_geneset_down in_range_up in_range_down contrast logFC_threshold p_val_threshold adjusted
## <chr> <int> <int> <int> <dbl> <dbl> <lgl> <lgl> <chr> <dbl> <dbl> <lgl>
## 1 CD8T 7915 310 73 0.0392 0.00922 TRUE TRUE Tumor-Normal 0.75 0.05 FALSE
## 2 CLEC9A 8901 649 328 0.0729 0.0368 TRUE TRUE Tumor-Normal 0.75 0.05 FALSE
## 3 Fibroblast 10494 696 721 0.0663 0.0687 TRUE TRUE Tumor-Normal 0.75 0.05 FALSE
## 4 KC_other 10982 1009 779 0.0919 0.0709 TRUE TRUE Tumor-Normal 0.75 0.05 FALSE
## 5 CD8T 7915 73 310 0.00922 0.0392 TRUE TRUE Normal-Tumor 0.75 0.05 FALSE
## 6 CLEC9A 8901 328 649 0.0368 0.0729 TRUE TRUE Normal-Tumor 0.75 0.05 FALSE
## 7 Fibroblast 10494 721 696 0.0687 0.0663 TRUE TRUE Normal-Tumor 0.75 0.05 FALSE
## 8 KC_other 10982 779 1009 0.0709 0.0919 TRUE TRUE Normal-Tumor 0.75 0.05 FALSENow we are in range for all cell types, and we will therefore proceed with these tresholds for the ligand activity analysis.
After the ligand activity prediction, we will also infer the predicted target genes of these ligands in each contrast. For this ligand-target inference procedure, we also need to select which top n of the predicted target genes will be considered (here: top 250 targets per ligand). This parameter will not affect the ligand activity predictions. It will only affect ligand-target visualizations and construction of the intercellular regulatory network during the downstream analysis. We recommend users to test other settings in case they would be interested in exploring fewer, but more confident target genes, or vice versa.
top_n_target = 250The NicheNet ligand activity analysis can be run in parallel for each receiver cell type, by changing the number of cores as defined here. Using more cores will speed up the analysis at the cost of needing more memory. This is only recommended if you have many receiver cell types of interest.
verbose = TRUE
cores_system = 8
n.cores = min(cores_system, celltype_de$cluster_id %>% unique() %>% length()) Running the ligand activity prediction will take some time (the more cell types and contrasts, the more time)
ligand_activities_targets_DEgenes = suppressMessages(suppressWarnings(
get_ligand_activities_targets_DEgenes(
receiver_de = celltype_de,
receivers_oi = intersect(receivers_oi, celltype_de$cluster_id %>% unique()),
ligand_target_matrix = ligand_target_matrix,
logFC_threshold = logFC_threshold,
p_val_threshold = p_val_threshold,
p_val_adj = p_val_adj,
top_n_target = top_n_target,
verbose = verbose,
n.cores = n.cores
)
))You can check the output of the ligand activity and ligand-target inference here:
ligand_activities_targets_DEgenes$ligand_activities %>% head(20)
## # A tibble: 20 × 8
## # Groups: receiver, contrast [1]
## ligand activity contrast target ligand_target_weight receiver direction_regulation activity_scaled
## <chr> <dbl> <chr> <chr> <dbl> <chr> <fct> <dbl>
## 1 A2M 0.0335 Tumor-Normal BIRC5 0.00940 CD8T up 0.286
## 2 A2M 0.0335 Tumor-Normal BST2 0.00662 CD8T up 0.286
## 3 A2M 0.0335 Tumor-Normal CCL20 0.00678 CD8T up 0.286
## 4 A2M 0.0335 Tumor-Normal CCL5 0.00888 CD8T up 0.286
## 5 A2M 0.0335 Tumor-Normal CCNA2 0.00880 CD8T up 0.286
## 6 A2M 0.0335 Tumor-Normal CD70 0.00689 CD8T up 0.286
## 7 A2M 0.0335 Tumor-Normal CDK1 0.00814 CD8T up 0.286
## 8 A2M 0.0335 Tumor-Normal CDK4 0.00751 CD8T up 0.286
## 9 A2M 0.0335 Tumor-Normal CDK6 0.00889 CD8T up 0.286
## 10 A2M 0.0335 Tumor-Normal CDKN2C 0.00726 CD8T up 0.286
## 11 A2M 0.0335 Tumor-Normal CKS1B 0.00744 CD8T up 0.286
## 12 A2M 0.0335 Tumor-Normal CORO1C 0.00677 CD8T up 0.286
## 13 A2M 0.0335 Tumor-Normal CSF2 0.00859 CD8T up 0.286
## 14 A2M 0.0335 Tumor-Normal DDX60 0.00714 CD8T up 0.286
## 15 A2M 0.0335 Tumor-Normal DNMT1 0.00746 CD8T up 0.286
## 16 A2M 0.0335 Tumor-Normal GEM 0.00689 CD8T up 0.286
## 17 A2M 0.0335 Tumor-Normal HMGB2 0.00672 CD8T up 0.286
## 18 A2M 0.0335 Tumor-Normal IFNG 0.0100 CD8T up 0.286
## 19 A2M 0.0335 Tumor-Normal IL2RA 0.00743 CD8T up 0.286
## 20 A2M 0.0335 Tumor-Normal JUN 0.0136 CD8T up 0.286In the previous steps, we calculated expression, differential expression and NicheNet ligand activity. In the final step, we will now combine all calculated information to rank all sender-ligand---receiver-receptor pairs according to group/condition specificity. We will use the following criteria to prioritize ligand-receptor interactions:
- Upregulation of the ligand in a sender cell type and/or upregulation of the receptor in a receiver cell type - in the condition of interest.
- Cell-type specific expression of the ligand in the sender cell type and receptor in the receiver cell type in the condition of interest (to mitigate the influence of upregulated but still relatively weakly expressed ligands/receptors).
- Sufficiently high expression levels of ligand and receptor in many samples of the same group.
- High NicheNet ligand activity, to further prioritize ligand-receptor pairs based on their predicted effect of the ligand-receptor interaction on the gene expression in the receiver cell type.
We will combine these prioritization criteria in a single aggregated prioritization score. In the default setting, we will weigh each of these criteria equally (scenario = "regular"). This setting is strongly recommended. However, we also provide some additional setting to accomodate different biological scenarios. The setting scenario = "lower_DE" halves the weight for DE criteria and doubles the weight for ligand activity. This is recommended in case your hypothesis is that the differential CCC patterns in your data are less likely to be driven by DE (eg in cases of differential migration into a niche). The setting scenario = "no_frac_LR_expr" ignores the criterion "Sufficiently high expression levels of ligand and receptor in many samples of the same group". This may be interesting for users that have data with a limited number of samples and don’t want to penalize interactions if they are not sufficiently expressed in some samples.
Finally, we still need to make one choice. For NicheNet ligand activity we can choose to prioritize ligands that only induce upregulation of target genes (ligand_activity_down = FALSE) or can lead potentially lead to both up- and downregulation (ligand_activity_down = TRUE). The benefit of ligand_activity_down = FALSE is ease of interpretability: prioritized ligand-receptor pairs will be upregulated in the condition of interest, just like their target genes. ligand_activity_down = TRUE can be harder to interpret because target genes of some interactions may be upregulated in the other conditions compared to the condition of interest. This is harder to interpret, but may help to pick up interactions that can also repress gene expression.
Here we will choose for setting ligand_activity_down = FALSE and focus specifically on upregulating ligands.
ligand_activity_down = FALSEsender_receiver_tbl = sender_receiver_de %>% distinct(sender, receiver)
metadata_combined = SummarizedExperiment::colData(sce) %>% tibble::as_tibble()
if(!is.na(batches)){
grouping_tbl = metadata_combined[,c(sample_id, group_id, batches)] %>%
tibble::as_tibble() %>% distinct()
colnames(grouping_tbl) = c("sample","group",batches)
} else {
grouping_tbl = metadata_combined[,c(sample_id, group_id)] %>%
tibble::as_tibble() %>% distinct()
colnames(grouping_tbl) = c("sample","group")
}
prioritization_tables = suppressMessages(generate_prioritization_tables(
sender_receiver_info = abundance_expression_info$sender_receiver_info,
sender_receiver_de = sender_receiver_de,
ligand_activities_targets_DEgenes = ligand_activities_targets_DEgenes,
contrast_tbl = contrast_tbl,
sender_receiver_tbl = sender_receiver_tbl,
grouping_tbl = grouping_tbl,
scenario = "regular", # all prioritization criteria will be weighted equally
fraction_cutoff = fraction_cutoff,
abundance_data_receiver = abundance_expression_info$abundance_data_receiver,
abundance_data_sender = abundance_expression_info$abundance_data_sender,
ligand_activity_down = ligand_activity_down
))Check the output tables
First: group-based summary table
prioritization_tables$group_prioritization_tbl %>% head(20)
## # A tibble: 20 × 18
## contrast group sender receiver ligand receptor lr_interaction id scaled_lfc_ligand scaled_p_val_ligand_…¹ scaled_lfc_receptor scaled_p_val_recepto…²
## <chr> <chr> <chr> <chr> <chr> <chr> <chr> <chr> <dbl> <dbl> <dbl> <dbl>
## 1 Tumor-Normal Tumor Fibroblast Fibroblast COL5A1 ITGA1 COL5A1_ITGA1 COL5A1_I… 0.908 0.957 0.971 0.991
## 2 Tumor-Normal Tumor Fibroblast Fibroblast COL1A1 ITGA1 COL1A1_ITGA1 COL1A1_I… 0.879 0.960 0.971 0.991
## 3 Tumor-Normal Tumor Fibroblast Fibroblast WNT5A FZD1 WNT5A_FZD1 WNT5A_FZ… 0.994 0.996 0.917 0.907
## 4 Tumor-Normal Tumor Fibroblast Fibroblast COL4A1 ITGA1 COL4A1_ITGA1 COL4A1_I… 0.957 0.987 0.971 0.991
## 5 Tumor-Normal Tumor Fibroblast KC_other TGFB3 ITGB6 TGFB3_ITGB6 TGFB3_IT… 0.934 0.956 0.945 0.955
## 6 Tumor-Normal Tumor Fibroblast Fibroblast COL5A3 ITGA1 COL5A3_ITGA1 COL5A3_I… 0.963 0.979 0.971 0.991
## 7 Tumor-Normal Tumor Fibroblast Fibroblast POSTN PTK7 POSTN_PTK7 POSTN_PT… 0.972 0.993 0.976 0.998
## 8 Tumor-Normal Tumor Fibroblast Fibroblast COL6A3 ITGA1 COL6A3_ITGA1 COL6A3_I… 0.884 0.962 0.971 0.991
## 9 Tumor-Normal Tumor Fibroblast Fibroblast COL5A1 DDR2 COL5A1_DDR2 COL5A1_D… 0.908 0.957 0.856 0.906
## 10 Tumor-Normal Tumor Fibroblast Fibroblast COL1A1 DDR2 COL1A1_DDR2 COL1A1_D… 0.879 0.960 0.856 0.906
## 11 Tumor-Normal Tumor CLEC9A CD8T IL15 IL2RA IL15_IL2RA IL15_IL2… 0.865 0.916 0.955 0.938
## 12 Tumor-Normal Tumor Fibroblast Fibroblast COL18A1 ITGA1 COL18A1_ITGA1 COL18A1_… 0.938 0.977 0.971 0.991
## 13 Tumor-Normal Tumor Fibroblast KC_other TNC ITGB6 TNC_ITGB6 TNC_ITGB… 0.978 0.995 0.945 0.955
## 14 Tumor-Normal Tumor Fibroblast Fibroblast COL4A2 ITGA1 COL4A2_ITGA1 COL4A2_I… 0.945 0.983 0.971 0.991
## 15 Tumor-Normal Tumor Fibroblast Fibroblast COL5A2 ITGA1 COL5A2_ITGA1 COL5A2_I… 0.937 0.979 0.971 0.991
## 16 Tumor-Normal Tumor Fibroblast Fibroblast COL3A1 ITGA1 COL3A1_ITGA1 COL3A1_I… 0.887 0.961 0.971 0.991
## 17 Tumor-Normal Tumor CD8T CLEC9A IFNG IFNGR2 IFNG_IFNGR2 IFNG_IFN… 0.932 0.961 0.793 0.873
## 18 Normal-Tumor Normal Fibroblast Fibroblast FGF7 FGFR1 FGF7_FGFR1 FGF7_FGF… 0.928 0.970 0.725 0.788
## 19 Tumor-Normal Tumor Fibroblast Fibroblast COL5A3 DDR2 COL5A3_DDR2 COL5A3_D… 0.963 0.979 0.856 0.906
## 20 Tumor-Normal Tumor CLEC9A CD8T CXCL9 CXCR3 CXCL9_CXCR3 CXCL9_CX… 0.921 0.970 0.818 0.804
## # ℹ abbreviated names: ¹scaled_p_val_ligand_adapted, ²scaled_p_val_receptor_adapted
## # ℹ 6 more variables: max_scaled_activity <dbl>, scaled_pb_ligand <dbl>, scaled_pb_receptor <dbl>, fraction_expressing_ligand_receptor <dbl>, prioritization_score <dbl>,
## # top_group <chr>This table gives the final prioritization score of each interaction, and the values of the individual prioritization criteria.
With this step, all required steps are finished. Now, we can optionally still run the following steps
- Calculate the across-samples expression correlation between ligand-receptor pairs and target genes
- Prioritize communication patterns involving condition-specific cell types through an alternative prioritization scheme
Here we will only focus on the expression correlation step:
In multi-sample datasets, we have the opportunity to look whether expression of ligand-receptor across all samples is correlated with the expression of their by NicheNet predicted target genes. This is what we will do with the following line of code:
lr_target_prior_cor = lr_target_prior_cor_inference(
receivers_oi = prioritization_tables$group_prioritization_tbl$receiver %>% unique(),
abundance_expression_info = abundance_expression_info,
celltype_de = celltype_de,
grouping_tbl = grouping_tbl,
prioritization_tables = prioritization_tables,
ligand_target_matrix = ligand_target_matrix,
logFC_threshold = logFC_threshold,
p_val_threshold = p_val_threshold,
p_val_adj = p_val_adj
)To avoid needing to redo the analysis later, we will here to save an output object that contains all information to perform all downstream analyses.
path = "./"
multinichenet_output = list(
celltype_info = abundance_expression_info$celltype_info,
celltype_de = celltype_de,
sender_receiver_info = abundance_expression_info$sender_receiver_info,
sender_receiver_de = sender_receiver_de,
ligand_activities_targets_DEgenes = ligand_activities_targets_DEgenes,
prioritization_tables = prioritization_tables,
grouping_tbl = grouping_tbl,
lr_target_prior_cor = lr_target_prior_cor
)
multinichenet_output = make_lite_output(multinichenet_output)
save = FALSE
if(save == TRUE){
saveRDS(multinichenet_output, paste0(path, "multinichenet_output.rds"))
}In a first instance, we will look at the broad overview of prioritized interactions via condition-specific Chordiagram circos plots.
We will look here at the top 50 predictions across all contrasts, senders, and receivers of interest.
prioritized_tbl_oi_all = get_top_n_lr_pairs(
multinichenet_output$prioritization_tables,
top_n = 50,
rank_per_group = FALSE
)prioritized_tbl_oi =
multinichenet_output$prioritization_tables$group_prioritization_tbl %>%
filter(id %in% prioritized_tbl_oi_all$id) %>%
distinct(id, sender, receiver, ligand, receptor, group) %>%
left_join(prioritized_tbl_oi_all)
prioritized_tbl_oi$prioritization_score[is.na(prioritized_tbl_oi$prioritization_score)] = 0
senders_receivers = union(prioritized_tbl_oi$sender %>% unique(), prioritized_tbl_oi$receiver %>% unique()) %>% sort()
colors_sender = RColorBrewer::brewer.pal(n = length(senders_receivers), name = 'Spectral') %>% magrittr::set_names(senders_receivers)
colors_receiver = RColorBrewer::brewer.pal(n = length(senders_receivers), name = 'Spectral') %>% magrittr::set_names(senders_receivers)
circos_list = make_circos_group_comparison(prioritized_tbl_oi, colors_sender, colors_receiver)
Whereas these ChordDiagrams show the most specific interactions per group, they don't give insights into the data behind these predictions. Therefore we will now look at visualizations that indicate the different prioritization criteria used in MultiNicheNet.
In the next type of plots, we will 1) visualize the per-sample scaled product of normalized ligand and receptor pseudobulk expression, 2) visualize the scaled ligand activities, 3) cell-type specificity.
We will now check the top 50 interactions specific for the Tumor-tissue
group_oi = "Tumor"prioritized_tbl_oi_Tumor_50 = get_top_n_lr_pairs(
multinichenet_output$prioritization_tables,
top_n = 50,
groups_oi = group_oi)plot_oi = make_sample_lr_prod_activity_plots(
multinichenet_output$prioritization_tables,
prioritized_tbl_oi_Tumor_50)
plot_oi
As a further help for further prioritization, we can assess the level of curation of these LR pairs as defined by the Intercellular Communication part of the Omnipath database
prioritized_tbl_oi_Tumor_50_omnipath = prioritized_tbl_oi_Tumor_50 %>%
inner_join(lr_network_all)Now we add this to the bubble plot visualization:
plot_oi = make_sample_lr_prod_activity_plots_Omnipath(
multinichenet_output$prioritization_tables,
prioritized_tbl_oi_Tumor_50_omnipath)
plot_oi
Further note: Typically, there are way more than 50 differentially expressed and active ligand-receptor pairs per group across all sender-receiver combinations. Therefore it might be useful to zoom in on specific cell types as senders/receivers:
Eg CLEC9A DCs as receiver:
prioritized_tbl_oi_Tumor_50 = get_top_n_lr_pairs(
multinichenet_output$prioritization_tables,
50,
groups_oi = group_oi,
receivers_oi = "CLEC9A")plot_oi = make_sample_lr_prod_activity_plots_Omnipath(
multinichenet_output$prioritization_tables,
prioritized_tbl_oi_Tumor_50 %>% inner_join(lr_network_all))
plot_oi
Eg CLEC9A as sender:
prioritized_tbl_oi_Tumor_50 = get_top_n_lr_pairs(
multinichenet_output$prioritization_tables,
50,
groups_oi = group_oi,
senders_oi = "CLEC9A")plot_oi = make_sample_lr_prod_activity_plots_Omnipath(
multinichenet_output$prioritization_tables,
prioritized_tbl_oi_Tumor_50 %>% inner_join(lr_network_all))
plot_oi
You can make these plots also for the other groups, like we will illustrate now for the S group
group_oi = "Normal"prioritized_tbl_oi_Normal_50 = get_top_n_lr_pairs(
multinichenet_output$prioritization_tables,
50,
groups_oi = group_oi)
plot_oi = make_sample_lr_prod_activity_plots_Omnipath(
multinichenet_output$prioritization_tables,
prioritized_tbl_oi_Normal_50 %>% inner_join(lr_network_all))
plot_oi
Note: Use make_sample_lr_prod_activity_batch_plots if you have batches and want to visualize them on this plot!
In another type of plot, we can visualize the ligand activities for a group-receiver combination, and show the predicted ligand-target links, and also the expression of the predicted target genes across samples.
For this, we now need to define a receiver cell type of interest. As example, we will take CLEC9A cells as receiver, and look at the top 10 senderLigand-receiverReceptor pairs with these cells as receiver.
group_oi = "Tumor"
receiver_oi = "CLEC9A"
prioritized_tbl_oi_Tumor_10 = get_top_n_lr_pairs(
multinichenet_output$prioritization_tables,
10,
groups_oi = group_oi,
receivers_oi = receiver_oi)combined_plot = make_ligand_activity_target_plot(
group_oi,
receiver_oi,
prioritized_tbl_oi_Tumor_10,
multinichenet_output$prioritization_tables,
multinichenet_output$ligand_activities_targets_DEgenes, contrast_tbl,
multinichenet_output$grouping_tbl,
multinichenet_output$celltype_info,
ligand_target_matrix,
plot_legend = FALSE)
combined_plot
## $combined_plot
##
## $legends
What if there is a specific ligand you are interested in?
group_oi = "Tumor"
receiver_oi = "CLEC9A"
ligands_oi = c("CSF1","CSF2")
prioritized_tbl_ligands_oi = get_top_n_lr_pairs(
multinichenet_output$prioritization_tables,
10000,
groups_oi = group_oi,
receivers_oi = receiver_oi
) %>% filter(ligand %in% ligands_oi) # ligands should still be in the output tables of coursecombined_plot = make_ligand_activity_target_plot(
group_oi,
receiver_oi,
prioritized_tbl_ligands_oi,
multinichenet_output$prioritization_tables,
multinichenet_output$ligand_activities_targets_DEgenes,
contrast_tbl,
multinichenet_output$grouping_tbl,
multinichenet_output$celltype_info,
ligand_target_matrix,
plot_legend = FALSE)
combined_plot
## $combined_plot
##
## $legends
In the previous plots, target genes were shown that are predicted as target gene of ligands based on prior knowledge. However, we can use the multi-sample nature of this data to filter target genes based on expression correlation between the upstream ligand-receptor pair and the downstream target gene. We will filter out correlated ligand-receptor --> target links that both show high expression correlation (spearman or pearson correlation > 0.50 in this example) and have some prior knowledge to support their link. Note that you can only make these visualization if you ran step 7 of the core MultiNicheNet analysis.
group_oi = "Tumor"
receiver_oi = "CLEC9A"
lr_target_prior_cor_filtered = multinichenet_output$lr_target_prior_cor %>%
inner_join(
multinichenet_output$ligand_activities_targets_DEgenes$ligand_activities %>%
distinct(ligand, target, direction_regulation, contrast)
) %>%
inner_join(contrast_tbl) %>% filter(group == group_oi, receiver == receiver_oi)
lr_target_prior_cor_filtered_up = lr_target_prior_cor_filtered %>%
filter(direction_regulation == "up") %>%
filter( (rank_of_target < top_n_target) & (pearson > 0.50 | spearman > 0.50))
lr_target_prior_cor_filtered_down = lr_target_prior_cor_filtered %>%
filter(direction_regulation == "down") %>%
filter( (rank_of_target < top_n_target) & (pearson < -0.50 | spearman < -0.50)) # downregulation -- negative correlation
lr_target_prior_cor_filtered = bind_rows(
lr_target_prior_cor_filtered_up,
lr_target_prior_cor_filtered_down)Now we will visualize the top correlated target genes for the LR pairs that are also in the top 50 LR pairs discriminating the groups from each other:
prioritized_tbl_oi = get_top_n_lr_pairs(
multinichenet_output$prioritization_tables,
50,
groups_oi = group_oi,
receivers_oi = receiver_oi)lr_target_correlation_plot = make_lr_target_correlation_plot(
multinichenet_output$prioritization_tables,
prioritized_tbl_oi,
lr_target_prior_cor_filtered ,
multinichenet_output$grouping_tbl,
multinichenet_output$celltype_info,
receiver_oi,
plot_legend = FALSE)
lr_target_correlation_plot$combined_plot
You can also visualize the expression correlation in the following way for a selected LR pair and their targets:
ligand_oi = "IFNG"
receptor_oi = "IFNGR2"
sender_oi = "CD8T"
receiver_oi = "CLEC9A"
lr_target_scatter_plot = make_lr_target_scatter_plot(
multinichenet_output$prioritization_tables,
ligand_oi, receptor_oi, sender_oi, receiver_oi,
multinichenet_output$celltype_info,
multinichenet_output$grouping_tbl,
lr_target_prior_cor_filtered)
lr_target_scatter_plot
In the plots before, we demonstrated that some DE genes have both expression correlation and prior knowledge support to be downstream of ligand-receptor pairs. Interestingly, some target genes can be ligands or receptors themselves. This illustrates that cells can send signals to other cells, who as a response to these signals produce signals themselves to feedback to the original sender cells, or who will effect other cell types.
As last plot, we can generate a 'systems' view of these intercellular feedback and cascade processes than can be occuring between the different cell populations involved. In this plot, we will draw links between ligands of sender cell types their ligand/receptor-annotated target genes in receiver cell types. So links are ligand-target links (= gene regulatory links) and not ligand-receptor protein-protein interactions! We will infer this intercellular regulatory network here for the top50 interactions. You can increase this to include more hits of course (recommended).
prioritized_tbl_oi = get_top_n_lr_pairs(
multinichenet_output$prioritization_tables,
50,
rank_per_group = FALSE)
lr_target_prior_cor_filtered =
multinichenet_output$prioritization_tables$group_prioritization_tbl$group %>% unique() %>%
lapply(function(group_oi){
lr_target_prior_cor_filtered = multinichenet_output$lr_target_prior_cor %>%
inner_join(
multinichenet_output$ligand_activities_targets_DEgenes$ligand_activities %>%
distinct(ligand, target, direction_regulation, contrast)
) %>%
inner_join(contrast_tbl) %>% filter(group == group_oi)
lr_target_prior_cor_filtered_up = lr_target_prior_cor_filtered %>%
filter(direction_regulation == "up") %>%
filter( (rank_of_target < top_n_target) & (pearson > 0.50 | spearman > 0.50))
lr_target_prior_cor_filtered_down = lr_target_prior_cor_filtered %>%
filter(direction_regulation == "down") %>%
filter( (rank_of_target < top_n_target) & (pearson < -0.50 | spearman < -0.50))
lr_target_prior_cor_filtered = bind_rows(
lr_target_prior_cor_filtered_up,
lr_target_prior_cor_filtered_down
)
}) %>% bind_rows()
lr_target_df = lr_target_prior_cor_filtered %>%
distinct(group, sender, receiver, ligand, receptor, id, target, direction_regulation) network = infer_intercellular_regulatory_network(lr_target_df, prioritized_tbl_oi)
network$links %>% head()
## # A tibble: 6 × 6
## sender_ligand receiver_target direction_regulation group type weight
## <chr> <chr> <fct> <chr> <chr> <dbl>
## 1 Fibroblast_COL1A1 Fibroblast_COL1A1 up Tumor Ligand-Target 1
## 2 Fibroblast_COL1A1 Fibroblast_COL4A1 up Tumor Ligand-Target 1
## 3 Fibroblast_COL1A1 Fibroblast_COL5A1 up Tumor Ligand-Target 1
## 4 Fibroblast_COL1A1 Fibroblast_FN1 up Tumor Ligand-Target 1
## 5 Fibroblast_COL1A1 Fibroblast_MMP1 up Tumor Ligand-Target 1
## 6 Fibroblast_COL1A1 Fibroblast_TGFB3 up Tumor Ligand-Target 1
network$nodes %>% head()
## # A tibble: 6 × 4
## node celltype gene type_gene
## <chr> <chr> <chr> <chr>
## 1 Fibroblast_COL1A1 Fibroblast COL1A1 ligand
## 2 Fibroblast_COL3A1 Fibroblast COL3A1 ligand
## 3 Fibroblast_POSTN Fibroblast POSTN ligand
## 4 Fibroblast_COL6A2 Fibroblast COL6A2 ligand
## 5 Fibroblast_COL6A1 Fibroblast COL6A1 ligand
## 6 Fibroblast_MMP1 Fibroblast MMP1 ligandnetwork_graph = visualize_network(network, colors_sender)
network_graph$plot
Interestingly, we can also use this network to further prioritize differential CCC interactions. Here we will assume that the most important LR interactions are the ones that are involved in this intercellular regulatory network. We can get these interactions as follows:
network$prioritized_lr_interactions
## # A tibble: 40 × 5
## group sender receiver ligand receptor
## <chr> <chr> <chr> <chr> <chr>
## 1 Tumor Fibroblast Fibroblast COL1A1 ITGA1
## 2 Tumor Fibroblast Fibroblast COL3A1 ITGA1
## 3 Tumor Fibroblast Fibroblast COL1A1 DDR2
## 4 Tumor Fibroblast Fibroblast POSTN PTK7
## 5 Tumor Fibroblast Fibroblast COL6A2 ITGA1
## 6 Tumor Fibroblast Fibroblast COL3A1 DDR2
## 7 Tumor Fibroblast Fibroblast COL6A1 ITGA1
## 8 Tumor Fibroblast Fibroblast MMP1 F2R
## 9 Tumor Fibroblast Fibroblast COL6A3 ITGA1
## 10 Tumor Fibroblast Fibroblast COL4A1 ITGA1
## # ℹ 30 more rowsprioritized_tbl_oi_network = prioritized_tbl_oi %>% inner_join(
network$prioritized_lr_interactions)
prioritized_tbl_oi_network
## # A tibble: 40 × 8
## group sender receiver ligand receptor id prioritization_score prioritization_rank
## <chr> <chr> <chr> <chr> <chr> <chr> <dbl> <dbl>
## 1 Tumor Fibroblast Fibroblast COL5A1 ITGA1 COL5A1_ITGA1_Fibroblast_Fibroblast 0.958 1
## 2 Tumor Fibroblast Fibroblast COL1A1 ITGA1 COL1A1_ITGA1_Fibroblast_Fibroblast 0.957 2
## 3 Tumor Fibroblast Fibroblast WNT5A FZD1 WNT5A_FZD1_Fibroblast_Fibroblast 0.953 3
## 4 Tumor Fibroblast Fibroblast COL4A1 ITGA1 COL4A1_ITGA1_Fibroblast_Fibroblast 0.950 4
## 5 Tumor Fibroblast Fibroblast COL5A3 ITGA1 COL5A3_ITGA1_Fibroblast_Fibroblast 0.943 6
## 6 Tumor Fibroblast Fibroblast POSTN PTK7 POSTN_PTK7_Fibroblast_Fibroblast 0.943 7
## 7 Tumor Fibroblast Fibroblast COL6A3 ITGA1 COL6A3_ITGA1_Fibroblast_Fibroblast 0.943 8
## 8 Tumor Fibroblast Fibroblast COL5A1 DDR2 COL5A1_DDR2_Fibroblast_Fibroblast 0.941 9
## 9 Tumor Fibroblast Fibroblast COL1A1 DDR2 COL1A1_DDR2_Fibroblast_Fibroblast 0.940 10
## 10 Tumor CLEC9A CD8T IL15 IL2RA IL15_IL2RA_CLEC9A_CD8T 0.940 11
## # ℹ 30 more rowsVisualize now the expression and activity of these interactions for the Tumor group
group_oi = "Tumor"prioritized_tbl_oi_Tumor = prioritized_tbl_oi_network %>% filter(group == group_oi)
plot_oi = make_sample_lr_prod_activity_plots_Omnipath(
multinichenet_output$prioritization_tables,
prioritized_tbl_oi_Tumor %>% inner_join(lr_network_all)
)
plot_oi